Soluble Fas (sFas) protein expression levels in urine samples from pre-operated NMIBC patients were analyzed by ELISA and it was reported that a urinary sFas test might help to identify NMIBC patients that are at risk of tumor recurrence. This evidence concerns the gene FAS and neoplasm.